Daniel Meyers

11PUBLICATIONS
28CO-AUTHORS
Cancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 27, 2024
Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Under-Represented by Clinical Trials.

Daniel E Meyers, Rebekah Rittberg, David E Dawe

|Dec 22, 2023
Durvalumab-Associated Pneumonitis in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Real-World Population Study.

Chloe Ahryung Lim, Sunita Ghosh, Hali Morrison

|Oct 27, 2022
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab.

Siddhartha Goutam, Igor Stukalin, Benjamin Ewanchuk

|Jun 13, 2022
Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians?

Kristin Wright, Daniel E Meyers, Timothy M Chisamore

|Dec 13, 2021
The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma.

Shantanu Banerji, Daniel E Meyers, Craig Harlos

Pageof 2